Dr. Girouard is Senior Director, Emerging Technologies in the Corporate Office of Science and Technology at Johnson & Johnson. Based in Cleveland, Ohio, Dr. Girouard is responsible for identifying emerging health care technologies and business opportunities in the Midwest. In this role, he works with faculty, researchers, entrepreneurs, technology incubators and early-stage investors to identify innovative products and business opportunities that may provide future growth across the Johnson & Johnson Family of Companies. Dr. Girouard earned an undergraduate degree in Biomedical Engineering from Boston University and his Master’s and Doctoral degrees in Biomedical Engineering from Case Western Reserve University.
Dr. Girouard started his career at Guidant Corporation in the Cardiac Rhythm Management division where he held various technology management positions. As Director of Basic Research at Guidant his responsibilities included the development of breakthrough cardiovascular technologies through a combination of internal and external research and development programs. Dr. Girouard was recruited to the Cleveland Clinic to serve as the founding Executive Director of the Atrial Fibrillation Innovation Center, a center created for the development of novel technologies for the treatment of atrial fibrillation. Dr. Girouard was previously a partner with Omega Funds and Oakwood Medical Investors where he focused on cardiovascular opportunities and medical devices. He holds over twenty patents and has authored numerous peer-reviewed articles and book chapters in the fields of cardiology and electrophysiology.